# IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients

> **NCT06558305** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** blood sample

## Key facts

- **NCT ID:** NCT06558305
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-03
- **Final completion:** 2025-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558305, "IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06558305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*